HHS grants liability protection to drugmakers pursuing hantavirus treatments

May 27, 2026

1. Ebola outbreak tops 900 cases: 7 updates Full story

2. HHS grants liability shield for unapproved hantavirus drug Full story

3. What does AI denial prevention actually look like in CDI workflows? Find out here.

 

4. NIH director testifies on staff turnover, funding cuts before Senate committee: 3 notes Full story

5. Blood, stool-based tests added to CRC screening guidelines Full story

6. Where are ASC margins really leaking? Get the answer leaders agreed on here.

 

7. AI in diagnostics: 10 findings healthcare leaders should know Full story

Becker’s Learning Opportunities

8. How Providence’s genomics model accelerates treatment decisions + expands clinical trial access: here.

9. Preparing for 2027 starts now. Address coding gaps and align teams to protect revenue and compliance here.

10. Multidisciplinary cardiovascular care, done right: Inside OHSU and NewYork-Presbyterian’s approach here.

11. Becker’s resources don’t stop here — explore more webinars and whitepapers.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 
 

 

Contact Us, Feedback, or Questions – Email ldyrda@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker’s Hospital Review, A Becker’s Healthcare Publication